Cost-Effectiveness Analysis of Botulinum Toxin Type a Treatment for Cerebral Palsy

To conduct a cost-effectiveness analysis of abobotulinumtoxinA+standard therapy (ST), onabotulinumtoxinA+ST and standard therapy solely in patients with spastic cerebral palsy in Russia for 2-year period. Standard therapy includes centrally acting muscle relaxant, physiotherapy, casting and orthosis.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: R Yagudina, A Kulikov, D Ugrekhelidze Source Type: research